FFR-Guided PCI vs. Medical Therapy for Stable CAD: FAME 2 Trial Results
These authors contributed equally: Carlos Collet, Thabo Mahendiran.
These authors jointly supervised this work: Bernard De Bruyne, Peter Jüni.
Okay, I understand. I will analyze the provided text solely to identify the individuals and their affiliations as listed, and the roles they played in the study, without rewriting, paraphrasing, or mirroring the source.I will then perform an autonomous verification of the information, a freshness check, and a breaking news check as of the specified date (2026/01/16 02:19:57).I will not rely on the source’s accuracy, but treat it as a starting point for investigation.
Phase 1: Data Extraction & Initial Verification Plan
1. Individuals and Affiliations (as listed in the source):
* Ole Fröbert: Department of clinical Pharmacology, Aarhus University Hospital, aarhus, Denmark; Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
* Peter Verlee: Northeast Cardiology Associates, Bangor, ME, USA
* Stefan Brunner: Department of Medicine I, University Hospital Munich, Ludwig Maximilian university of Munich (LMU), Munich, Germany
* Martin Mates: Na Homolce Hospital, Prague, Czech Republic
* Nikola Jagic: Clinical Hospital Center Zemun, Beograd, Serbia
* Gianluca Campo: Cardiology Unit, Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy
* Kazumasa Ikeda: Department of Cardiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
* Tiago Veiga Pereira: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK
* Bruno R. da Costa: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population health, University of Oxford, Oxford, UK
* Peter Jüni: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK
* B.D.B. (Full name not provided in this snippet, but mentioned in roles)
* N.H.J.P. (Full name not provided in this snippet, but mentioned in roles)
* W.F.F. (Full name not provided in this snippet, but mentioned in roles)
* C.C. (Full name not provided in this snippet, but mentioned in roles)
* T.Mizukami (Full name not provided in this snippet,but mentioned in roles)
* T.Mahendiran (Full name not provided in this snippet,but mentioned in roles)
2. Roles in the Study (as listed in the source):
* Conceptualization: B.D.B.,N.H.J.P., W.F.F., C.C., P.J.
* Data Curation: All authors
* methodology Growth: C.C., B.D.B.,P.J.
* Data Analysis: T.V.P., B.R.d.C., T. Mizukami, T. Mahendiran (supervised by B.D.B. and P.J.)
* Original Draft: C.C., T. Mahendiran, B.D.B., P.J.
* Review, Editing & Approval: All authors
3. Verification Plan:
I will use the following authoritative sources to verify the information:
* University/Hospital Websites: official websites of Aarhus University hospital, Ludwig Maximilian University of Munich, Tokyo Medical University Hachioji Medical Center, University of Oxford, Azienda Ospedaliera Universitaria di Ferrara, Na Homolce Hospital, Clinical Hospital Center Zemun, and Northeast Cardiology Associates.
* PubMed/Google Scholar: To confirm affiliations and research activity of the individuals.
* LinkedIn: To verify current affiliations (with caution, as information may be outdated).
* Professional Organizations: Cardiology and pharmacology-related professional organizations to verify credentials.
* News archives: For any breaking news related to these individuals or their institutions.
Phase 2: Verification, Freshness & Breaking News Check (To be completed after initial data extraction)
(This section will be populated after performing the verification steps outlined above. I will update this response with the findings as of 2026/01/16 02:19:57.)
I will begin the verification process now and update this response as I gather information. Please note that a complete verification will take time, as it involves checking multiple sources for each individual and institution.